Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | CCR1 | P32246 | 3/20 | 0.38 |
| ▸ | CCR5 | P51681 | 3/20 | 0.38 |
| ▸ | CCR8 | P51685 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | METAP1 | P53582 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.38 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 6/20 | 0.34 |
| ▸ | TP53 | P04637 | 4/20 | 0.34 |
| ▸ | RAB9A | P51151 | 4/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28757531 | 0.98 | KDM4E (0.37) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL28584537 | 0.79 | — | — | |
| SCHEMBL14080610 | 0.77 | — | — | |
| SCHEMBL9582375 | 0.77 | KDM4E (0.36) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL28379974 | 0.76 | MAOA (0.31) | — | |
| SCHEMBL28379953 | 0.76 | MAOA (0.31) | — | |
| Hydrochloric Acid SCHEMBL28432953 | 0.76 | MAOA (0.31) | — | |
| SCHEMBL28381602 | 0.76 | MAOA (0.31) | — | |
| SCHEMBL28741713 | 0.76 | MAOA (0.31) | — | |
| SCHEMBL11331090 | 0.76 | MAOA (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119039608-B | Photosensitive molecular junction with photoelectric response rectification function and preparation method and application thereof | 广东工业大学 | 2025-01-21 | — | — | CN | claimed |
| CN-119039608-A | Photosensitive molecular junction with photoelectric response rectification function and preparation method and application thereof | 广东工业大学 | 2024-11-29 | — | — | CN | claimed |
| US-20240148749-A1 | MNTBAP AND M(III)N-SUBSTITUTED PYRIDYLPORPHYRINS(MNPS)FOR USE IN REVERSING SEPSIS-INDUCED MICROGLIAL CELLS ALTERATIONS AND/OR FOR TREATING SEPSIS OR SEPSIS-ASSOCIATED ENCEPHALOPATHY | PASTEUR INSTITUT (FR) | 2024-05-09 | — | — | US | claimed |
| EP-4308107-A1 | MNTBAP AND M(III)N-SUBSTITUTED PYRIDYLPORPHYRINS(MNPS)FOR USE IN REVERSING SEPSIS-INDUCED MICROGLIAL CELLS ALTERATIONS AND/OR FOR TREATING SEPSIS OR SEPSIS-ASSOCIATED ENCEPHALOPATHY | INSTITUT PASTEUR (FR) | 2024-01-24 | — | — | EP | claimed |
| CN-116902960-A | N and S co-doped carbon material, preparation method and application thereof in zinc-air battery | 大连民族大学 | 2023-10-20 | — | — | CN | claimed |
| CN-116875194-A | Tungsten chemical mechanical polishing solution and application thereof | 万华化学集团电子材料有限公司 | 2023-10-13 | — | — | CN | claimed |
| US-20230310404-A1 | COMPOSITIONS AND METHODS FOR REDUCING LAMINITIS OF AN ANIMAL HOOF | EQUINE PODIATRY SOLUTIONS LLC (US) | 2023-10-05 | — | — | US | claimed |
| CN-115160582-B | Crystalline trimetallic pyridine porphyrin porous complex and preparation method and application thereof | 闽都创新实验室 | 2023-09-05 | — | — | CN | claimed |
| CN-116598501-A | Composite lithium-rich material, preparation method thereof, positive electrode and secondary battery | 深圳市德方创域新能源科技有限公司 | 2023-08-15 | — | — | CN | claimed |
| CN-113555564-B | Preparation of supported non-noble metal electrocatalyst with MIL-88 as carrier and application of supported non-noble metal electrocatalyst in oxygen reduction reaction | 大连民族大学 | 2023-06-20 | — | — | CN | claimed |
| CN-104650104-B | The preparation method of zinc ion-porphyrin nano complex | 深圳市正科技有限公司 | 2017-01-04 | — | — | CN | claimed |
| CN-105688995-A | Method for preparing metalloporphyrin-graphene nano composite material under condition of room temperature | 湖南科技大学 | 2016-06-22 | — | — | CN | claimed |
| US-20150376218-A1 | METHOD FOR MANUFACTURING NITROGEN-CONTAINING CARBON ALLOY, NITROGEN-CONTAINING CARBON ALLOY, AND FUEL CELL CATALYST | FUJIFILM CORPORATION (JP) | 2015-12-31 | — | — | US | claimed |
| CN-104862373-A | High-throughput screening method of photodynamic antibacterial photosensitizer | UNIV HEBEI TECHNOLOGY | 2015-08-26 | — | — | CN | claimed |
| CN-104650104-A | Preparation method of zinc ion-porphyrin nanometer complex | SHENZHEN E ZHENG TECH CO LTD | 2015-05-27 | — | — | CN | claimed |
| CN-104253225-A | Preparation method of large-area ordered organic p-n junction nanowire array | CHINESE ACAD INST CHEMISTRY | 2014-12-31 | — | — | CN | claimed |
| US-8530614-B1 | Porphyrin coordination polymer nanospheres and nanorods | SANDIA CORPORATION (US) | 2013-09-10 | — | — | US | claimed |
| US-8324342-B1 | Porphyrin coordination polymer nanospheres and nanorods | SANDIA CORPORATION (US) | 2012-12-04 | — | — | US | claimed |
| CN-102408452-A | Tetrapyridylporphyrin bridged cross-shaped tetranuclear platinum complex and preparation method and antitumor activity thereof | UNIV SUN YAT SEN | 2012-04-11 | — | — | CN | claimed |
| CN-1450066-A | Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant | GONG XIANCHANG (CN) | 2003-10-22 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240148749-A1 | MNTBAP AND M(III)N-SUBSTITUTED PYRIDYLPORPHYRINS(MNPS)FOR USE IN REVERSING SEPSIS-INDUCED MICROGLIAL CELLS ALTERATIONS AND/OR FOR TREATING SEPSIS OR SEPSIS-ASSOCIATED ENCEPHALOPATHY | PEBP1, TPX2, MPEG1 | KDM4E 1621/4885LMNA 3412/4885CCR1 1438/4885 |
| US-20150376218-A1 | METHOD FOR MANUFACTURING NITROGEN-CONTAINING CARBON ALLOY, NITROGEN-CONTAINING CARBON ALLOY, AND FUEL CELL CATALYST | CA3, NIT2, NOX3 | KDM4E 2821/4885LMNA 4584/4885CCR1 3072/4885 |
| US-20230310404-A1 | COMPOSITIONS AND METHODS FOR REDUCING LAMINITIS OF AN ANIMAL HOOF | COX15, HMOX2, HMOX1 | KDM4E 3417/4885LMNA 84/4885CCR1 3037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.